STOCK TITAN

[Form 4] Workday, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Pitney Bowes Inc. (NYSE: PBI) – Form 144 filed for proposed insider sale

The notice, dated 07/14/2025, covers a planned sale of 5,000 common shares with an aggregate market value of $55,050. The transaction will be executed through Morgan Stanley Smith Barney on the NYSE. The shares equal roughly 0.003 % of Pitney Bowes’ 181,253,371 shares outstanding.

All shares were acquired as restricted stock units on 02/09/2021. The filer—identified in prior 10b5-1 disclosures as Lauren Thomas Defina—has already sold 4,000 shares over the last three months:

  • 2,000 shares on 07/03/2025 for $23,000
  • 2,000 shares on 06/26/2025 for $22,000

The signer certifies no knowledge of undisclosed adverse information and, if relying on Rule 10b5-1, affirms an existing trading plan. Given the modest size relative to float, the sale is expected to have minimal impact on liquidity or fundamentals, though investors may note the continuation of insider selling activity.

Pitney Bowes Inc. (NYSE: PBI) – Presentazione del Modulo 144 per una vendita interna proposta

Il comunicato, datato 14/07/2025, riguarda una vendita pianificata di 5.000 azioni ordinarie con un valore di mercato complessivo di 55.050 $. La transazione sarà eseguita tramite Morgan Stanley Smith Barney alla NYSE. Le azioni rappresentano circa lo 0,003 % delle 181.253.371 azioni in circolazione di Pitney Bowes.

Tutte le azioni sono state acquisite come unità di azioni vincolate (restricted stock units) il 09/02/2021. Il dichiarante — identificato in precedenti comunicazioni 10b5-1 come Lauren Thomas Defina — ha già venduto 4.000 azioni negli ultimi tre mesi:

  • 2.000 azioni il 03/07/2025 per 23.000 $
  • 2.000 azioni il 26/06/2025 per 22.000 $

Il firmatario certifica di non essere a conoscenza di informazioni negative non divulgate e, qualora si avvalga della Regola 10b5-1, conferma l’esistenza di un piano di trading. Data la dimensione modesta rispetto al flottante, la vendita dovrebbe avere un impatto minimo sulla liquidità o sui fondamentali, anche se gli investitori potrebbero notare la continuazione dell’attività di vendita da parte degli insider.

Pitney Bowes Inc. (NYSE: PBI) – Presentación del Formulario 144 para una venta interna propuesta

El aviso, fechado el 14/07/2025, cubre una venta planeada de 5.000 acciones ordinarias con un valor de mercado total de 55.050 $. La transacción se realizará a través de Morgan Stanley Smith Barney en la NYSE. Las acciones representan aproximadamente el 0,003 % de las 181.253.371 acciones en circulación de Pitney Bowes.

Todas las acciones fueron adquiridas como unidades de acciones restringidas (restricted stock units) el 09/02/2021. El declarante — identificado en divulgaciones previas 10b5-1 como Lauren Thomas Defina — ya ha vendido 4.000 acciones en los últimos tres meses:

  • 2.000 acciones el 03/07/2025 por 23.000 $
  • 2.000 acciones el 26/06/2025 por 22.000 $

El firmante certifica no tener conocimiento de información adversa no divulgada y, si se basa en la Regla 10b5-1, afirma la existencia de un plan de negociación. Dado el tamaño modesto en relación con el flotante, se espera que la venta tenga un impacto mínimo en la liquidez o los fundamentos, aunque los inversores pueden notar la continuación de la actividad de venta interna.

Pitney Bowes Inc. (NYSE: PBI) – 내부자 매도 예정에 대한 Form 144 제출

2025년 7월 14일자 통지서는 5,000주 보통주를 총 시장 가치 55,050달러에 매도할 계획을 담고 있습니다. 거래는 NYSE에서 Morgan Stanley Smith Barney를 통해 진행됩니다. 해당 주식은 Pitney Bowes의 총 발행 주식 181,253,371주 중 약 0.003 %에 해당합니다.

모든 주식은 2021년 2월 9일에 제한부 주식 단위(Restricted Stock Units)로 취득되었습니다. 제출자는 이전 10b5-1 공시에 따라 Lauren Thomas Defina로 확인되었으며, 지난 3개월 동안 이미 4,000주를 매도했습니다:

  • 2025년 7월 3일에 2,000주 매도, 23,000달러
  • 2025년 6월 26일에 2,000주 매도, 22,000달러

서명자는 미공개 부정적 정보를 알지 못함을 증명하며, 10b5-1 규칙에 의존하는 경우 기존 거래 계획이 있음을 확인합니다. 유통 주식 수에 비해 규모가 작아 이번 매도는 유동성이나 기초 체력에 미치는 영향이 미미할 것으로 예상되나, 투자자들은 내부자 매도 활동이 계속되고 있음을 주목할 수 있습니다.

Pitney Bowes Inc. (NYSE : PBI) – Dépôt du formulaire 144 pour une vente interne proposée

L'avis, daté du 14/07/2025, concerne une vente prévue de 5 000 actions ordinaires d'une valeur marchande totale de 55 050 $. La transaction sera réalisée via Morgan Stanley Smith Barney sur le NYSE. Ces actions représentent environ 0,003 % des 181 253 371 actions en circulation de Pitney Bowes.

Toutes les actions ont été acquises sous forme de unités d'actions restreintes (restricted stock units) le 09/02/2021. Le déclarant — identifié dans des divulgations 10b5-1 antérieures comme Lauren Thomas Defina — a déjà vendu 4 000 actions au cours des trois derniers mois :

  • 2 000 actions le 03/07/2025 pour 23 000 $
  • 2 000 actions le 26/06/2025 pour 22 000 $

Le signataire certifie ne pas avoir connaissance d'informations défavorables non divulguées et, s'il se fonde sur la règle 10b5-1, confirme l'existence d'un plan de trading. Étant donné la taille modeste par rapport au flottant, la vente devrait avoir un impact minimal sur la liquidité ou les fondamentaux, bien que les investisseurs puissent noter la poursuite des ventes par les initiés.

Pitney Bowes Inc. (NYSE: PBI) – Einreichung von Formular 144 für geplanten Insider-Verkauf

Die Mitteilung vom 14.07.2025 betrifft einen geplanten Verkauf von 5.000 Stammaktien mit einem Gesamtmarktwert von 55.050 $. Die Transaktion wird über Morgan Stanley Smith Barney an der NYSE abgewickelt. Die Aktien entsprechen etwa 0,003 % der 181.253.371 ausstehenden Aktien von Pitney Bowes.

Alle Aktien wurden am 09.02.2021 als Restricted Stock Units erworben. Der Meldende – in früheren 10b5-1 Offenlegungen als Lauren Thomas Defina identifiziert – hat in den letzten drei Monaten bereits 4.000 Aktien verkauft:

  • 2.000 Aktien am 03.07.2025 für 23.000 $
  • 2.000 Aktien am 26.06.2025 für 22.000 $

Der Unterzeichner bestätigt, keine Kenntnis von nicht veröffentlichten negativen Informationen zu haben und, falls er sich auf Regel 10b5-1 stützt, einen bestehenden Handelsplan zu bejahen. Aufgrund der geringen Größe im Verhältnis zum Streubesitz wird erwartet, dass der Verkauf minimale Auswirkungen auf Liquidität oder Fundamentaldaten hat, obwohl Anleger die Fortsetzung der Insider-Verkäufe zur Kenntnis nehmen könnten.

Positive
  • None.
Negative
  • Continued insider selling: the filer has sold or plans to sell 9,000 shares within three months, which some investors may view as a weak confidence signal despite the small size.

Insights

TL;DR: 5k-share Form 144 is routine; dollar value <0.01 % of market cap, limited impact.

The filing reveals a proposed $55k sale (≈0.003 % of outstanding shares) by RSU holder Lauren Thomas Defina. Coupled with 4k shares sold in June–July under a 10b5-1 plan, insider disposals total 9k shares. The transaction does not alter Pitney Bowes’ capital structure or signal operational issues—the form expressly states no undisclosed adverse information. From an equity-market perspective, the volume is immaterial and should not pressure the stock. The event remains noteworthy only for those monitoring insider sentiment.

Pitney Bowes Inc. (NYSE: PBI) – Presentazione del Modulo 144 per una vendita interna proposta

Il comunicato, datato 14/07/2025, riguarda una vendita pianificata di 5.000 azioni ordinarie con un valore di mercato complessivo di 55.050 $. La transazione sarà eseguita tramite Morgan Stanley Smith Barney alla NYSE. Le azioni rappresentano circa lo 0,003 % delle 181.253.371 azioni in circolazione di Pitney Bowes.

Tutte le azioni sono state acquisite come unità di azioni vincolate (restricted stock units) il 09/02/2021. Il dichiarante — identificato in precedenti comunicazioni 10b5-1 come Lauren Thomas Defina — ha già venduto 4.000 azioni negli ultimi tre mesi:

  • 2.000 azioni il 03/07/2025 per 23.000 $
  • 2.000 azioni il 26/06/2025 per 22.000 $

Il firmatario certifica di non essere a conoscenza di informazioni negative non divulgate e, qualora si avvalga della Regola 10b5-1, conferma l’esistenza di un piano di trading. Data la dimensione modesta rispetto al flottante, la vendita dovrebbe avere un impatto minimo sulla liquidità o sui fondamentali, anche se gli investitori potrebbero notare la continuazione dell’attività di vendita da parte degli insider.

Pitney Bowes Inc. (NYSE: PBI) – Presentación del Formulario 144 para una venta interna propuesta

El aviso, fechado el 14/07/2025, cubre una venta planeada de 5.000 acciones ordinarias con un valor de mercado total de 55.050 $. La transacción se realizará a través de Morgan Stanley Smith Barney en la NYSE. Las acciones representan aproximadamente el 0,003 % de las 181.253.371 acciones en circulación de Pitney Bowes.

Todas las acciones fueron adquiridas como unidades de acciones restringidas (restricted stock units) el 09/02/2021. El declarante — identificado en divulgaciones previas 10b5-1 como Lauren Thomas Defina — ya ha vendido 4.000 acciones en los últimos tres meses:

  • 2.000 acciones el 03/07/2025 por 23.000 $
  • 2.000 acciones el 26/06/2025 por 22.000 $

El firmante certifica no tener conocimiento de información adversa no divulgada y, si se basa en la Regla 10b5-1, afirma la existencia de un plan de negociación. Dado el tamaño modesto en relación con el flotante, se espera que la venta tenga un impacto mínimo en la liquidez o los fundamentos, aunque los inversores pueden notar la continuación de la actividad de venta interna.

Pitney Bowes Inc. (NYSE: PBI) – 내부자 매도 예정에 대한 Form 144 제출

2025년 7월 14일자 통지서는 5,000주 보통주를 총 시장 가치 55,050달러에 매도할 계획을 담고 있습니다. 거래는 NYSE에서 Morgan Stanley Smith Barney를 통해 진행됩니다. 해당 주식은 Pitney Bowes의 총 발행 주식 181,253,371주 중 약 0.003 %에 해당합니다.

모든 주식은 2021년 2월 9일에 제한부 주식 단위(Restricted Stock Units)로 취득되었습니다. 제출자는 이전 10b5-1 공시에 따라 Lauren Thomas Defina로 확인되었으며, 지난 3개월 동안 이미 4,000주를 매도했습니다:

  • 2025년 7월 3일에 2,000주 매도, 23,000달러
  • 2025년 6월 26일에 2,000주 매도, 22,000달러

서명자는 미공개 부정적 정보를 알지 못함을 증명하며, 10b5-1 규칙에 의존하는 경우 기존 거래 계획이 있음을 확인합니다. 유통 주식 수에 비해 규모가 작아 이번 매도는 유동성이나 기초 체력에 미치는 영향이 미미할 것으로 예상되나, 투자자들은 내부자 매도 활동이 계속되고 있음을 주목할 수 있습니다.

Pitney Bowes Inc. (NYSE : PBI) – Dépôt du formulaire 144 pour une vente interne proposée

L'avis, daté du 14/07/2025, concerne une vente prévue de 5 000 actions ordinaires d'une valeur marchande totale de 55 050 $. La transaction sera réalisée via Morgan Stanley Smith Barney sur le NYSE. Ces actions représentent environ 0,003 % des 181 253 371 actions en circulation de Pitney Bowes.

Toutes les actions ont été acquises sous forme de unités d'actions restreintes (restricted stock units) le 09/02/2021. Le déclarant — identifié dans des divulgations 10b5-1 antérieures comme Lauren Thomas Defina — a déjà vendu 4 000 actions au cours des trois derniers mois :

  • 2 000 actions le 03/07/2025 pour 23 000 $
  • 2 000 actions le 26/06/2025 pour 22 000 $

Le signataire certifie ne pas avoir connaissance d'informations défavorables non divulguées et, s'il se fonde sur la règle 10b5-1, confirme l'existence d'un plan de trading. Étant donné la taille modeste par rapport au flottant, la vente devrait avoir un impact minimal sur la liquidité ou les fondamentaux, bien que les investisseurs puissent noter la poursuite des ventes par les initiés.

Pitney Bowes Inc. (NYSE: PBI) – Einreichung von Formular 144 für geplanten Insider-Verkauf

Die Mitteilung vom 14.07.2025 betrifft einen geplanten Verkauf von 5.000 Stammaktien mit einem Gesamtmarktwert von 55.050 $. Die Transaktion wird über Morgan Stanley Smith Barney an der NYSE abgewickelt. Die Aktien entsprechen etwa 0,003 % der 181.253.371 ausstehenden Aktien von Pitney Bowes.

Alle Aktien wurden am 09.02.2021 als Restricted Stock Units erworben. Der Meldende – in früheren 10b5-1 Offenlegungen als Lauren Thomas Defina identifiziert – hat in den letzten drei Monaten bereits 4.000 Aktien verkauft:

  • 2.000 Aktien am 03.07.2025 für 23.000 $
  • 2.000 Aktien am 26.06.2025 für 22.000 $

Der Unterzeichner bestätigt, keine Kenntnis von nicht veröffentlichten negativen Informationen zu haben und, falls er sich auf Regel 10b5-1 stützt, einen bestehenden Handelsplan zu bejahen. Aufgrund der geringen Größe im Verhältnis zum Streubesitz wird erwartet, dass der Verkauf minimale Auswirkungen auf Liquidität oder Fundamentaldaten hat, obwohl Anleger die Fortsetzung der Insider-Verkäufe zur Kenntnis nehmen könnten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Garfield Mark S.

(Last) (First) (Middle)
C/O WORKDAY, INC.
6110 STONERIDGE MALL ROAD

(Street)
PLEASANTON CA 94588

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Workday, Inc. [ WDAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/10/2025 S(1) 451 D $234.86(2) 42,977(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person dated October 12, 2024.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices within the range of $234.86 to $235.8599, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
3. Includes 41,560 restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of Class A Common Stock upon settlement. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates.
Remarks:
/s/ Juliana Capata, attorney-in-fact 07/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Pitney Bowes (PBI) shares are covered by this Form 144?

The notice covers 5,000 common shares.

What is the aggregate market value of the planned sale?

The filing lists an aggregate value of $55,050 for the 5,000 shares.

When is the approximate date of sale for the PBI shares?

The shares are expected to be sold on 07/14/2025.

Which broker will execute the transaction?

The sale will be handled by Morgan Stanley Smith Barney LLC.

How many shares has the same insider sold recently?

She previously sold 4,000 shares (2,000 on 07/03/2025 and 2,000 on 06/26/2025).

What percentage of Pitney Bowes’ outstanding shares does the 5,000-share sale represent?

It represents roughly 0.003 % of the 181,253,371 shares outstanding.

What type of shares are being sold and when were they acquired?

They are restricted stock units acquired on 02/09/2021.
Workday Inc

NASDAQ:WDAY

WDAY Rankings

WDAY Latest News

WDAY Latest SEC Filings

WDAY Stock Data

64.11B
214.05M
0.9%
95.76%
2.86%
Software - Application
Services-computer Processing & Data Preparation
Link
United States
PLEASANTON